In another study, it was reported that MALAT-1 knockdown resulted in the upregulation of miR-101 and downregulation of glycogen synthase kinase (GSK)-3β in resistant glioblastoma cells, hence overcoming the temozolomide-MDR in the cells (Figure 4) [110]. The gene discussed is MALAT1; the disease is glioblastoma.